Exelixis
EXEL
#1671
Rank
A$15.43 B
Marketcap
$54.05
Share price
-0.58%
Change (1 day)
64.40%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $76.40 AUD on 2000-07-26

Lowest end of day price: $2.00 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$51.82-1.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
$74.52 0.46%๐Ÿ‡ซ๐Ÿ‡ท France
$151.15-0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$87.71-3.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$437.07-4.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$239.11 1.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$38.56-4.48%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.07-1.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.27 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA